Emerging intracellular bacterial infections

Clinics in Laboratory Medicine

Volumn 24, Issue 3, 2004, Pages 627-649

  Katz, Brenda ^a   Waites, Ken ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASMA PHAGOCYTOPHILUM; ASTHMA; ATHEROSCLEROSIS; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BRONCHIOLITIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; EHRLICHIA CHAFFEENSIS; HOST PATHOGEN INTERACTION; HUMAN; INFLAMMATORY DISEASE; MULTIPLE SCLEROSIS; MYCOPLASMA PNEUMONIAE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RICKETTSIA;

CHLAMYDIA INFECTIONS; COMMUNICABLE DISEASES, EMERGING; HUMANS; MYCOPLASMA INFECTIONS; RICKETTSIA INFECTIONS;

EID: 8444241443     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2004.05.005     Document Type: Review

References (66)

1. Nauciel C. Immune defenses against intracellular bacterial infections. Paradise L., Friedman H., Bendinelli M. Opportunistic intracellular bacteria and immunity. 1999;1-16 Plenum Press, New York
2. Aguero-Rosenfeld M., Dumler J. Ehrlichia, Anaplasma, Neorickettsia, and Aegyptianella. Murray P., Baron E., Jorgensen J., Pfaller M., Yolken R. 8th edition Manual of clinical microbiology. Vol. 1:2003;1015-1029 American Society for Microbiology, Washington, DC
3. Himmelreich R., Hilbert H., Plagens H., Pirkl E., Li B.C., Herrmann R. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res. 24:1996;4420-4449
4. Meseguer M.A., Alvarez A., Rejas M.T., Sanchez C., Perez-Diaz J.C., Baquero F. Mycoplasma pneumoniae: a reduced-genome intracellular bacterial pathogen. Infect Genet Evol. 3:2003;47-55
5. Dallo S.F., Baseman J.B. Intracellular DNA replication and long-term survival of pathogenic mycoplasmas. Microb Pathog. 29:2000;301-309
6. Rottem S. Interaction of mycoplasmas with host cells. Physiol Rev. 83:2003;417-432
7. Tryon V.V., Baseman J.B. Pathogenic determinants and mechanisms. Maniloff J. Mycoplasmas, molecular biology and pathogenesis. 1992;457-471 American Society for Microbiology, Washington, DC
8. Talkington D.F., Waites K.B., Schwartz S.B., Besser R.E. Emerging from obscurity: understanding pulmonary and extrapulmonary syndromes, pathogenesis, and epidemiology of human Mycoplasma pneumoniae infections. Scheld W.M., Craig W.A., Hughes J.M. Emerging infections 5. 2001;57-84 American Society for Microbiology, Washington, DC
9. Foy H.M. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis. 17:(Suppl 1):1993;S37-S46
10. Jacobs E., Vonski M., Oberle K., Opitz O., Pietsch K. Are outbreaks and sporadic respiratory infections by Mycoplasma pneumoniae due to two distinct subtypes? Eur J Clin Microbiol Infect Dis. 15:1996;38-44
11. Block S., Hedrick J., Hammerschlag M.R., Cassell G.H., Craft J.C. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J. 14:1995;471-477
12. Marston B.J., Plouffe J.F., File T.M. Jr., Hackman B.A., Salstrom S.J., Lipman H., et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med. 157:1997;1709-1718
13. Waites K.B., Bebear C.M., Robertson J.A., Talkington D.F., Kenny G.E. Cumitech 34: laboratory diagnosis of mycoplasmal infections. CeFS Nolte. 2001;1-30 American Society for Microbiology, Washington, DC
14. Grayston J., Kuo C., Campbell L., Wang S. Chlamydia pneumoniae so. nov. for Chlamydia sp. strain TWAR. Int J Syst Bacteriol. 39:1989;88-90
15. Everett K.D., Bush R.M., Andersen A.A. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol. 49:(Pt 2):1999;415-440
16. Campbell L.A., Kuo C.C. Chlamydia pneumoniae pathogenesis. J Med Microbiol. 51:2002;623-625
17. Dowell S.F., Peeling R.W., Boman J., Carloa G.N., Fields B., et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis. 33:2001;492-503
18. Hammerschlag M.R., Roblin P.M. Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae. Int J Antimicrob Agents. 15:2000;149-152
19. Kraft M., Cassell G.H., Henson J.E., Watson H., Williamson J., Marmion B.P., et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med. 158:1998;998-1001
20. Gil J.C., Cedillo R.L., Mayagoitia B.G., Paz M.D. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann Allergy. 70:1993;23-25
21. Freymuth F., Vabret A., Brouard J., Toutain F., Verdon R., et al. Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol. 13:1999;131-139
22. Brouard J., Freymuth F., Toutain F., Bach N., Vabret A., Gouarin S., et al. Role of viral infections and Chlamydia pneumoniae and Mycoplasma pneumoniae infections in asthma in infants and young children. Epidemiologic study of 118 children. Arch Pediatr. 9:(Suppl 3):2002;365s-371s
23. Thumerelle C., Deschildre A., Bouquillon C., Santos C., Sardet A., Scalbert M., et al. Role of viruses and atypical bacteria in exacerbations of asthma in hospitalized children: a prospective study in the Nord-Pas de Calais region (France). Pediatr Pulmonol. 35:2003;75-82
24. Lieberman D., Printz S., Ben-Yaakov M., Lazarovich Z., Ohana B., Friedman M.G., et al. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med. 167:2003;406-410
25. Seggev J.S., Lis I., Siman-Tov R., Gutman R., Abu-Samaa H., Schey G., et al. Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. Ann Allergy. 57:1986;263-265
26. Kraft M., Cassell G.H., Pak J., Martin R.J. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest. 121:2002;1782-1788
27. Hoek K.L., Cassell G.H., Duffy L.B., Atkinson T.P. Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells. J Allergy Clin Immunol. 109:2002;470-476
28. Hahn D.L., Dodge R.W., Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA. 266:1991;225-230
29. Cook P.J., Davies P., Tunnicliffe W., Ayres J.G., Honeybourne D., Wise R. Chlamydia pneumoniae and asthma. Thorax. 53:1998;254-259
30. Allegra L., Blasi F., Centanni S., Cosentini R., Denti F., Raccanelli R., et al. Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection. Eur Respir J. 7:1994;2165-2168
31. Cunningham A.F., Johnston S.L., Julious S.A., Lampe F.C., Ward M.E. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J. 11:1998;345-349
32. Kamesaki S., Suehiro Y., Shinomiya K., Matsushima H., Ouchi K. Chlamydia pneumoniae infection in children with asthma exacerbation. Arerugi. 47:1998;667-673
33. Miyashita N., Kubota Y., Nakajima M., Niki Y., Kawane H., Matsushima T. Chlamydia pneumoniae and exacerbations of asthma in adults. Ann Allergy Asthma Immunol. 80:1998;405-409
34. Emre U., Roblin P.M., Gelling M., Dumornay W., Rao M., Hammerschlag M.R., et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med. 148:1994;727-732
35. Mogulkoc N., Karakurt S., Isalska B., Bayindir U., Celikel T., Korten V., et al. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am J Respir Crit Care Med. 160:1999;349-353
36. Lieberman D., Ben-Yaakov M., Shmarkov O., Gelfer Y., Varshavsky R., Ohana B., et al. Serological evidence of Mycoplasma pneumoniae infection in acute exacerbation of COPD. Diagn Microbiol Infect Dis. 44:2002;1-6
37. Lieberman D., Ben-Yaakov M., Lazarovich Z., Hoffman S., Ohana B., Friedman M.G., et al. Infectious etiologies in acute exacerbation of COPD. Diagn Microbiol Infect Dis. 40:2001;95-102
38. Lieberman D., Ben-Yaakov M., Lazarovich Z., Ohana B., Boldur I. Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease: analysis of 250 hospitalizations. Eur J Clin Microbiol Infect Dis. 20:2001;698-704
39. Llibre J.M., Urban A., Garcia E., Carrasco M.A., Murcia C. Bronchiolitis obliterans organizing pneumonia associated with acute Mycoplasma pneumoniae infection. Clin Infect Dis. 25:1997;1340-1342
40. Diehl J.H., Gisselbrecht M., Meyer G., Israel-Biet D., Sors H. Bronchiolitis obliterans organizing pneumonia associated with chlamydial infection. Eur Respir J. 9:1996;1320-1322
41. Chan E.D., Kalayanamit T., Lynch D.A., Tuder R., Arndt P., Winn R., et al. Mycoplasma pneumoniae-associated bronchiolitis causing severe restrictive lung disease in adults: report of three cases and literature review. Chest. 115:1999;1188-1194
42. Fraley D.S., Ruben F.L., Donnelly E.J. Respiratory failure secondary to Mycoplasma pneumoniae infection. South Med J. 72:1979;437-440
43. Coultas D.B., Samet J.M., Butler C. Bronchiolitis obliterans due to Mycoplasma pneumoniae. West J Med. 144:1986;471-474
44. Petersen N.T., Hoiby N., Mordhorst C.H., Lind K., Flensborg E.W., Bruun B. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma - possible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand. 70:1981;623-628
45. Ong E.L., Ellis M.E., Webb A.K., Neal K.R., Dodd M., Caul E.O., et al. Infective respiratory exacerbations in young adults with cystic fibrosis: role of viruses and atypical microorganisms. Thorax. 44:1989;739-742
46. Efthimiou J., Hodson M.E., Taylor P., Taylor A.G., Batten J.C. Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis. Thorax. 39:1984;150-154
47. Pribble C.G., Black P.G., Bosso J.A., Turner R.B. Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections. J Pediatrics. 117:1990;200-204
48. Emre U., Bernius M., Roblin P.M., Gaerlan H., Summersgill J.T., Steiner P., et al. Chlamydia pneumoniae infection in patients with cystic fibrosis. Clin Infect Dis. 22:1996;819-823
49. Ngeh J., Anand V., Gupta S. Chlamydia pneumoniae and atherosclerosis - what we know and what we don't. Clin Microbiol Infect. 8:2002;2-13
50. Fahdi I.E., Gaddam V., Garza L., Romeo F., Mehta J.L. Inflammation, infection, and atherosclerosis. Brain Behav Immun. 17:2003;238-244
51. Stratton C.W., Sriram S. Association of Chlamydia pneumoniae with central nervous system disease. Microbes Infect. 5:2003;1249-1253
52. Paddock C.D., Childs J.E. Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin Microbiol Rev. 16:2003;37-64
53. Bakken J.S., Dumler J.S., Chen S.M., Eckman M.R., Van Etta L.L., Walker D.H. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA. 272:1994;212-218
54. Carlyon J.A., Fikrig E. Invasion and survival strategies of Anaplasma phagocytophilum. Cell Microbiol. 5:2003;743-754
55. Rikihisa Y. Mechanisms to create a safe haven by members of the family Anaplasmataceae. Ann N Y Acad Sci. 990:2003;548-555
56. Lin M., Rikihisa Y. Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect Immun. 71:2003;5324-5331
57. Casadevall A. Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle. Infect Immun. 71:2003;4225-4228
58. Walker D., Bouyer D. Rickettsia. Murray P., Baron E., Jorgensen J., Pfaller M., Yolken R. 8th edition Manual of clinical microbiology. Vol. 1:2003;1005-1014 American Society for Microbiology, Washington, DC
59. Graves S., Stenos J. Rickettsia honei: a spotted fever group Rickettsia on three continents. Ann N Y Acad Sci. 990:2003;62-66
60. Heinzen R.A. Rickettsial actin-based motility: behavior and involvement of cytoskeletal regulators. Ann N Y Acad Sci. 990:2003;535-547
61. Walker D.H., Valbuena G.A., Olano J.P. Pathogenic mechanisms of diseases caused by Rickettsia. Ann N Y Acad Sci. 990:2003;1-11
62. Valbuena G., Feng H.M., Walker D.H. Mechanisms of immunity against rickettsiae. New perspectives and opportunities offered by unusual intracellular parasites. Microbes Infect. 4:2002;625-633
63. Winslow G.M., Yager E., Li J.S. Mechanisms of humoral immunity during Ehrlichia chaffeensis infection. Ann N Y Acad Sci. 990:2003;435-443
64. Paddock C.D., Sumner J.W., Comer J.A., et al. Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States. Clin Infect Dis. 38:2004;805-811
65. McQuiston J.H., Paddock C.D., Singleton J. Jr., Wheeling J.T., Zaki S.R., Childs J.E. Imported spotted fever rickettsioses in United States travelers returning from Africa: a summary of cases confirmed by laboratory testing at the Centers for Disease Control and Prevention, 1999-2002. Am J Trop Med Hyg. 70:2004;98-101
66. Jensenius M., Fournier P.E., Kelly P., Myrvang B., Raoult D. African tick bite fever. Lancet Infect Dis. 3:2003;557-564